123254-09-1

Usage

General Description

2-amino-3-(2-bromo-5-hydroxyphenyl)propanoic acid is a chemical compound with the molecular formula C9H10BrNO3. It is a derivative of the amino acid tyrosine, with a bromine atom and a hydroxyl group attached to the phenyl ring. 2-amino-3-(2-bromo-5-hydroxyphenyl)propanoic acid has potential applications in the field of pharmaceuticals and biotechnology, particularly in the development of drugs targeting specific receptors and enzymes. Its unique structure and properties make it a subject of interest in research related to the synthesis and characterization of new compounds for various medicinal purposes. Additionally, its structure suggests that it may have potential biological activities, making it a promising candidate for further investigation and development.

Upstream product

• 775-06-4 D/L-3-hydroxy-phenylalanine 

Relevant academic research and scientific papers

The scope and limitations of the Suzuki-Miyaura cross-coupling reactions of 6- and 8-substituted 1,2,3,4-tetrahydroisoquinoline-3-carboxylates

6- and 8-Aryl-1,2,3,4-tetrahydroisoqinoline-3-carboxylates have been prepared by Suzuki-Miyaura cross-coupling reactions of the triflates or corresponding boronate esters. We have shown for the first time that a one-pot arylation of a triflate via the bor

COMPOUNDS FOR BINDING PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9)

The present disclosure relates to novel compounds, methods, and compositions capable of binding to PCSK9, thereby modulating PCSK9 proprotein convertase enzyme activity. The compounds of the disclosure include compounds Formula (I).

Discovery of small-molecule nonpeptide antagonists of nociceptin/orphanin FQ receptor: The studies of design, synthesis, and structure-Activity relationships for (4-Arylpiperidine substituted-methyl)-[bicyclic (hetero)cycloalkanobenzene] derivatives

Nociceptin/orphanin FQ (N/OFQ) and N/OFQ peptide (NOP) receptor are expressed and distributed in various regions such as central nervous system (CNS), peripheral nervous system, immune system, and peripheral tissues. N/OFQ and NOP receptor have important

Substituted Tetrahydroisoquinolines as Beta-secretase Inhibitors

There is provided a series of tetrahydroisoquinoline diaminopropane compounds of Formula (I) or a stereoisomer; or a pharmaceutically acceptable salt thereof, wherein R, R8 and R9 are as defined herein, their pharmaceutical compositi